These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26474427)

  • 1. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
    Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
    Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
    Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
    Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
    Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
    Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
    PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases.
    Keck KJ; Breheny P; Braun TA; Darbro B; Li G; Dillon JS; Bellizzi AM; O'Dorisio TM; Howe JR
    Surgery; 2018 Jan; 163(1):232-239. PubMed ID: 29154080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
    Wang YC; Zuraek MB; Kosaka Y; Ota Y; German MS; Deneris ES; Bergsland EK; Donner DB; Warren RS; Nakakura EK
    Endocr Relat Cancer; 2010 Mar; 17(1):283-91. PubMed ID: 20048018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
    Farley HA; Pommier RF
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.
    Cui T; Tsolakis AV; Li SC; Cunningham JL; Lind T; Öberg K; Giandomenico V
    Eur J Endocrinol; 2013 Feb; 168(2):253-61. PubMed ID: 23184910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.
    Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36951556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
    Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors.
    Edfeldt K; Daskalakis K; Bäcklin C; Norlén O; Tiensuu Janson E; Westin G; Hellman P; Stålberg P
    Neuroendocrinology; 2017; 105(2):170-181. PubMed ID: 27829249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.
    Mourra N; Scriva A; Mansiaux Y; Gozlan S; Bennis M; Balaton A
    Histopathology; 2014 Nov; 65(5):642-50. PubMed ID: 24807631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
    Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
    World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in somatostatin receptor 2 (SSTR2) immunoreactivity is coupled to level of bowel invasion in small intestinal neuroendocrine tumors.
    Fotouhi O; Zedenius J; Höög A; Juhlin CC
    Neuro Endocrinol Lett; 2018 Oct; 39(4):305-309. PubMed ID: 30531706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
    Barazeghi E; Prabhawa S; Norlén O; Hellman P; Stålberg P; Westin G
    BMC Cancer; 2018 Jul; 18(1):764. PubMed ID: 30045709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine.
    Liu Q; Polydorides AD
    Mod Pathol; 2020 Nov; 33(11):2318-2329. PubMed ID: 32514164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.